FindTrial
Sign In

Research on treatment modalities exploration and prognostic factors of HIV-related Kaposi's sarcoma in Xinjiang

Research on treatment modalities exploration and prognostic factors of HIV-related Kaposi's sarcoma in Xinjiang

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-13003860
Enrollment
Unknown
Registered
2013-10-19
Start date
2013-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV-related Kaposi's sarcoma

Interventions

A:HAART
B:ABV regimen Chemotherapy
C:No treatment

Sponsors

First Clinical Medical College of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. HIV-1 antibody positive and treatment in Urumqi; 2. Have a clinical or pathological diagnosis of Kaposi's sarcoma.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Survival indicator;—

Countries

China

Contacts

Public ContactLu Xiaobo

First Clinical Medical College of Xinjiang Medical University

xjykdluxiaobo@126.com+86 15999176213

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026